Hypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do Better (Q29399489)

14 April 2017

author name string

Keith C. Ferdinand

series ordinal

1

1 reference

14 April 2017

Elijah Sounders

series ordinal

2

1 reference

14 April 2017

publication date

January 2006

1 reference

Journal of Clinical Hypertension

14 April 2017

published in

1 reference

14 April 2017

volume

8

1 reference

14 April 2017

issue

s1

1 reference

14 April 2017

page(s)

21-30

1 reference

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

14 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1524-6175.2006.05295.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

21 April 2017

Hypertension in blacks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Coronary heart disease and lipid-modifying treatment in African American patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Implications of the INTERSALT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Use of beta-adrenergic receptor blockers in blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Lessons from combination therapy in Veterans Affairs Studies. Department of Veterans Affairs Cooperative Study Group on antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05295.X

10.1111/J.1524-6175.2006.05295.X

21 January 2018

Identifiers

DOI

1 reference